AAAAAA

   
Results: 1-8 |
Results: 8
IDENTIFICATION OF CHROMOSOMAL GAINS AND LOSSES IN PEDIATRIC MALIGNANTASTROCYTOMA BY COMPARATIVE GENOMIC HYBRIDIZATION
Authors: WARR TJ WARD SJ DARLING JL THOMAS DGT
Citation: Tj. Warr et al., IDENTIFICATION OF CHROMOSOMAL GAINS AND LOSSES IN PEDIATRIC MALIGNANTASTROCYTOMA BY COMPARATIVE GENOMIC HYBRIDIZATION, British Journal of Cancer, 78, 1998, pp. 157-157
NONISOTOPIC MOLECULAR CYTOGENETICS IN NEUROONCOLOGY
Authors: DARLING JL WARR TJ ASHMORE SM LUXSUWONG M REVESZ T
Citation: Jl. Darling et al., NONISOTOPIC MOLECULAR CYTOGENETICS IN NEUROONCOLOGY, Neuropathology and applied neurobiology, 23(6), 1997, pp. 441-456
HETEROGENEITY OF CHEMOSENSITIVITY IN 6 CLONAL CELL-LINES DERIVED FROMA SPONTANEOUS MURINE ASTROCYTOMA AND ITS RELATIONSHIP TO GENOTYPIC AND PHENOTYPIC CHARACTERISTICS
Authors: BRADFORD R KOPPEL H PILKINGTON GJ THOMAS DGT DARLING JL
Citation: R. Bradford et al., HETEROGENEITY OF CHEMOSENSITIVITY IN 6 CLONAL CELL-LINES DERIVED FROMA SPONTANEOUS MURINE ASTROCYTOMA AND ITS RELATIONSHIP TO GENOTYPIC AND PHENOTYPIC CHARACTERISTICS, Journal of neuro-oncology, 34(3), 1997, pp. 247-261
PRETREATMENT PREDICTION OF THE CHEMOTHERAPEUTIC RESPONSE OF HUMAN GLIOMA CELL-CULTURES USING NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY AND ARTIFICIAL NEURAL NETWORKS
Authors: ELDEREDY W ASHMORE SM BRANSTON NM DARLING JL WILLIAMS SR THOMAS DGT
Citation: W. Elderedy et al., PRETREATMENT PREDICTION OF THE CHEMOTHERAPEUTIC RESPONSE OF HUMAN GLIOMA CELL-CULTURES USING NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY AND ARTIFICIAL NEURAL NETWORKS, Cancer research, 57(19), 1997, pp. 4196-4199
ASSAY OF ANTICANCER DRUGS IN TISSUE-CULTURE - COMPARISON OF A TETRAZOLIUM-BASED ASSAY AND A PROTEIN-BINDING DYE ASSAY IN SHORT-TERM CULTURES DERIVED FROM HUMAN-MALIGNANT GLIOMA
Authors: HASELSBERGER K PETERSON DC THOMAS DGT DARLING JL
Citation: K. Haselsberger et al., ASSAY OF ANTICANCER DRUGS IN TISSUE-CULTURE - COMPARISON OF A TETRAZOLIUM-BASED ASSAY AND A PROTEIN-BINDING DYE ASSAY IN SHORT-TERM CULTURES DERIVED FROM HUMAN-MALIGNANT GLIOMA, Anti-cancer drugs, 7(3), 1996, pp. 331-338
LOSS OF HETEROZYGOSITY FOR DNA POLYMORPHISMS MAPPING TO CHROMOSOME-10AND CHROMOSOME-17 AND PROGNOSIS IN PATIENTS WITH GLIOMAS
Authors: JONES CE DAVIS MB DARLING JL GEDDES JF THOMAS DGT HARDING AE
Citation: Ce. Jones et al., LOSS OF HETEROZYGOSITY FOR DNA POLYMORPHISMS MAPPING TO CHROMOSOME-10AND CHROMOSOME-17 AND PROGNOSIS IN PATIENTS WITH GLIOMAS, Journal of Neurology, Neurosurgery and Psychiatry, 58(2), 1995, pp. 218-221
DETECTION OF MULTIDRUG-RESISTANCE GENE-PRODUCT (P-GLYCOPROTEIN) EXPRESSION IN EPENDYMOMAS
Authors: GEDDES JF VOWLES GH ASHMORE SM COCKBURN HA DARLING JL
Citation: Jf. Geddes et al., DETECTION OF MULTIDRUG-RESISTANCE GENE-PRODUCT (P-GLYCOPROTEIN) EXPRESSION IN EPENDYMOMAS, Neuropathology and applied neurobiology, 20(2), 1994, pp. 118-121
PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) - EXPRESSION IN SAMPLES OF HUMAN ASTROCYTIC GLIOMAS
Authors: REVESZ T ALSANJARI N DARLING JL SCARAVILLI F LANE DP THOMAS DGT
Citation: T. Revesz et al., PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) - EXPRESSION IN SAMPLES OF HUMAN ASTROCYTIC GLIOMAS, Neuropathology and applied neurobiology, 19(2), 1993, pp. 152-158
Risultati: 1-8 |